Matthew McManus - Aug 15, 2024 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Role
President - DGS
Signature
/s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Aug 15, 2024
Transactions value $
$0
Form type
4/A - Amendment
Date filed
2/3/2025, 04:38 PM
Date Of Original Report
Aug 19, 2024
Previous filing
Feb 5, 2024
Next filing
Feb 4, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Performance Restricted Stock Units Award $0 +15.8K $0.00 15.8K Aug 15, 2024 Common Stock 15.8K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Remarks:

This amendment is being filed to correct the number of performance restricted stock units being granted.